Literature DB >> 1929821

Calciphylaxis in secondary hyperparathyroidism. Diagnosis and parathyroidectomy.

Q Y Duh1, R C Lim, O H Clark.   

Abstract

Calciphylaxis is a rare, severe complication of secondary hyperparathyroidism. Patients present with painful, violaceous, mottled skin lesions of the upper and lower extremities, which become necrotic and produce nonhealing ulcers. Gangrene of fingers and toes frequently requires amputation, produces nonhealing wounds, and can lead to sepsis and death. We reviewed the clinical course of five patients with calciphylaxis treated in our institution. The three men and two women (aged 47 to 72 years) had secondary hyperparathyroidism from chronic renal failure. All patients had severe pruritus, painful ulcers, and severe hyperphosphatemia with elevated serum calcium-phosphate product (greater than 12 mmol2/L2), but the serum parathyroid hormone levels were only moderately elevated. Most patients had medical calcification of medium and small blood vessels, and some had soft-tissue calcification visible on roentgenography. Treatment consisted of local wound care, antibiotics, phosphate-binding agents, and parathyroidectomy. Two patients died of uncontrollable sepsis. The three survivors had dramatic improvement of pain and ulcers after parathyroidectomy. Calciphylaxis is a limb- and life-threatening complication of secondary hyperparathyroidism. Diagnosis can be made by recognizing the characteristic painful skin lesions, ulcers, and gangrene of the digits, and patients should be treated with subtotal parathyroidectomy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1929821     DOI: 10.1001/archsurg.1991.01410340055008

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  11 in total

1.  Secondary and tertiary hyperparathyroidism: causes of recurrent disease after 446 parathyroidectomies.

Authors:  G Gasparri; M Camandona; G C Abbona; M Papotti; A Jeantet; E Radice; B Mullineris; M Dei Poli
Journal:  Ann Surg       Date:  2001-01       Impact factor: 12.969

2.  Case Report on Calciphylaxis: An Early Diagnosis and Treatment May Improve Outcome.

Authors:  Barbara J Marshall; Rachel E Johnson
Journal:  J Am Coll Clin Wound Spec       Date:  2013-11-12

3.  Painful skin ulcers in a hemodialysis patient.

Authors:  Stuart M Sprague
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 8.237

4.  [Results of surgical therapy in renal hyperparathyroidism. Follow-up of 143 patients].

Authors:  C Dotzenrath; P E Goretzki; H D Roher
Journal:  Langenbecks Arch Chir       Date:  1996

Review 5.  The surgical management of renal hyperparathyroidism.

Authors:  Catherine Madorin; Randall P Owen; William D Fraser; Phillip K Pellitteri; Brian Radbill; Alessandra Rinaldo; Raja R Seethala; Ashok R Shaha; Carl E Silver; Matthew Y Suh; Barrie Weinstein; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-11-20       Impact factor: 2.503

6.  Preventing bone disease requires diligent management in patients with renal failure.

Authors:  F O Kolb
Journal:  West J Med       Date:  1994-05

Review 7.  Surgical management of secondary hyperparathyroidism in chronic kidney disease--a consensus report of the European Society of Endocrine Surgeons.

Authors:  Kerstin Lorenz; Detlef K Bartsch; Juan J Sancho; Sebastien Guigard; Frederic Triponez
Journal:  Langenbecks Arch Surg       Date:  2015-10-02       Impact factor: 3.445

Review 8.  Calciphylaxis.

Authors:  R V Mathur; J R Shortland; A M el-Nahas
Journal:  Postgrad Med J       Date:  2001-09       Impact factor: 2.401

9.  Surgical management of calciphylaxis associated with primary hyperparathyroidism: a case report and review of the literature.

Authors:  Jennifer Bishop; Eric Brown; Augusto Podesta; Cathrine Troy; Xiang Eric Dong
Journal:  Int J Endocrinol       Date:  2010-08-16       Impact factor: 3.257

10.  Images - Penile pain in the setting of end-stage renal disease: An unusual anatomic location for calciphylaxis.

Authors:  Ummah Salma Nisar; John C Cheville; Charles D Sturgis
Journal:  Can Urol Assoc J       Date:  2022-05       Impact factor: 2.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.